Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
about
Releasing the brake: targeting Cbl-b to enhance lymphocyte effector functionsBreaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma modelThe role of the e3 ligase cbl-B in murine dendritic cells.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-cell Receptor Gene TherapyA novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.Cbl-b Deficiency Mediates Resistance to Programmed Death-Ligand 1/Programmed Death-1 Regulation.Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition.Engineering effective T-cell based antitumor immunity.Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.Cbl-b mediates TGFβ sensitivity by downregulating inhibitory SMAD7 in primary T cells.Regulation of Lymphatic GM-CSF Expression by the E3 Ubiquitin Ligase Cbl-b
P2860
Q21285001-64059085-7097-4886-A0D3-A3FE85E2F6F2Q26744624-88E6D06F-EAD4-4B10-B6AA-31F83B6E7B10Q27686800-A660E31A-FB5C-4CD6-BEF2-72F8489A69E8Q33953086-C502E312-5B01-43E8-B2C4-C2FED77B0894Q34409836-B213778E-3C5A-4ACA-854B-41ADF851B4CFQ34769671-E50BB896-422B-4819-B42A-F085A4D0C5C7Q36887833-06EC0383-EF91-4FE2-9BE1-3E25F15203CBQ36928580-30766F11-6FB5-4B67-A248-380CB5C6CD14Q37588247-B51A23B4-FC02-4887-8802-2DB22AFD220DQ37607147-AAB5E73F-3B57-4B00-B50E-54FED99928D2Q38393275-9BA015E5-838C-441D-9974-ADD84E0594ABQ41091768-ED97D9E8-77B0-4001-8E6A-76C8418A9E0AQ43225888-BCA9E581-47E1-4DEF-A003-E28C5CAF453FQ49240447-581841B4-2DBB-49E3-9932-CAB646B88653Q50794802-C2F711E7-6495-4D31-A385-3F0CDEEA098AQ50958644-4AA6A85E-A715-4364-9120-3799CB7B149BQ57817463-64C00470-0C1D-41C3-85B1-0DE22DFF8BAE
P2860
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Reinforcement of cancer immuno ...... ls combined with a DC vaccine.
@en
Reinforcement of cancer immuno ...... ls combined with a DC vaccine.
@nl
type
label
Reinforcement of cancer immuno ...... ls combined with a DC vaccine.
@en
Reinforcement of cancer immuno ...... ls combined with a DC vaccine.
@nl
prefLabel
Reinforcement of cancer immuno ...... ls combined with a DC vaccine.
@en
Reinforcement of cancer immuno ...... ls combined with a DC vaccine.
@nl
P2093
P2860
P50
P356
P1476
Reinforcement of cancer immuno ...... ls combined with a DC vaccine.
@en
P2093
Anna Maria Wolf
Christina Lutz-Nicoladoni
Dominik Wolf
Gottfried Baier
Günther Gastl
Magdalena Pircher
Stephanie Wallner
P2860
P304
P356
10.1038/ICB.2011.11
P577
2011-03-08T00:00:00Z